Product Wiki · Recalls · U.S. FDA — Food Enforcement

Gorilla Mind Rauwolscine Dietary Supplement, Suppress Appetite… — recall F-0053-2025

U.S. FDA — Food Enforcement · United States · 2024-09-06 · Class I

As described by U.S. FDA — Food Enforcement: Gorilla Mind Rauwolscine Dietary Supplement, Suppress Appetite, Increased Fat Loss, Increased Energy, dosage 3mg, 90 capsules per bottle, UPC 8 50017 02016 0. Product is manufactured for Gorilla Mind LLC 7154 W. State Street, STE 138, Boise, ID. Product label declares "***Supplement Facts: Rauwols

Compiled from an official source — the facts on this page are reproduced from the issuing authority’s own published notice, which is linked on this page. No AI-generated text appears on this page. How we use AI →
Agency
U.S. FDA — Food Enforcement
Recall identifier
F-0053-2025
Date of alert
2024-09-06
Country / jurisdiction
United States
Risk level
Class I
Notice type
recall
Brand
Gorilla Mind LLC
Product category
food
Product type
Food
Recall status
Terminated — the recall action is complete and the FDA has closed it
Initiated by
Voluntary: Firm initiated
Distribution
nationwide
Barcode (EAN/GTIN)
24041003
Reported risk: Product was recalled due to the potential for contamination with Salmonella
What to do

Check whether your product matches this notice (name, batch, dates). If it does, stop using it and follow the instructions in the official notice — refund, return, repair or disposal are set by the issuing authority and the business, and they differ per recall. Official notice from U.S. FDA — Food Enforcement →

Primary source: https://api.fda.gov/food/enforcement.json?search=recall_number:%22F-0053-2025%22

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.